Regulation of Dendritic Cell Migration to the Draining Lymph Node
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Antigen-pulsed dendritic cells (DCs) are used as natural adjuvants for vaccination, but the factors that influence the efficacy of this treatment are poorly understood. We investigated the parameters that affect the migration of subcutaneously injected mouse-mature DCs to the draining lymph node. We found that the efficiency of DC migration varied with the number of injected DCs and that CCR7+/+ DCs migrating to the draining lymph node, but not CCR7-/- DCs that failed to do so, efficiently induced a rapid increase in lymph node cellularity, which was observed before the onset of T cell proliferation. We also report that DC migration could be increased up to 10-fold by preinjection of inflammatory cytokines that increased the expression of the CCR7 ligand CCL21 in lymphatic endothelial cells. The magnitude and quality of CD4+ T cell response was proportional to the number of antigen-carrying DCs that reached the lymph node and could be boosted up to 40-fold by preinjection of tumor necrosis factor that conditioned the tissue for increased DC migration. These results indicate that DC number and tissue inflammation are critical parameters for DC-based vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mouse DCs start to enter the regional lymph node 18 hours after inoculation in the skin, reaching a maximum within 72 hours.50,51”
From Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells (2006) · cites this paper as [50]
Experimental — accuracy not yet measuredIn the citing paper
“besides their critical role for priming T cells in lymph nodes (Martin-Fontecha et al., 2003)”
From Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 (2018) · cites this paper as Martin-Fontecha et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336 · cited 1×
“Tissue-resident DCs and DC precursors, such as monocytes or immature DCs recruited from the blood, are stimulated by microbial products and inflammatory cytokines to undergo a coordinately regulated process of maturation and migration (1).”
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410 · cited 1×
“The finding that DC migration can be boosted by inflammatory stimuli through up-regulation of CCL21 on lymphatic endothelial cells was unexpected, because CCL21 has been considered the prototype of constitutive chemokines (27).”
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,367 · cited 5×
“Lack of CCR7 or its ligands leads to dramatic changes in DC and lymphocyte traffic and abnormal lymph node architecture (8, 9).”
InfluentialSelf-citationAlteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690 · cited 5×
“The fact that CCR7 / DCs, which are incapable of migrating to the lymph node, do not cause lymph node congestion indicates that this phenomenon is mediated by mature DCs that have reached the lymph node through mechanisms that still need to be identified but might be related to release of chemokines or S1P.”
InfluentialDieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., & Nakano, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.451 · Cited by 1,019 · cited 2×
“In plt/plt mice, which carry a spontaneous mutation that abolishes CCL19 expression and restricts CCL21 expression to the lymphatic endothelium, DCs and naive T cells fail to enter the T cell zone of secondary lymphoid organs (9, 10).”
Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., & Williams, L. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.258 · Cited by 1,001
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Cited by
Items 401–500 of 888
de Chickera, S. N., Snir, J. A., Willert, C., Rohani, R., Foley, R., Foster, P. J., & Dekaban, G. A. (2011) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.433 · Cited by 36
CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model
Nguyen-Hoai, T., Baldenhofer, G., Ahmed, M. S. S., Pham, D. M., Vu, M. D., Lipp, M., Dörken, B., Pezzutto, A., & Westermann, J. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2011.69 · Cited by 34
Self-citationVγ4 γδ T Cells Provide an Early Source of IL-17A and Accelerate Skin Graft Rejection
Li, Y., Huang, Z., Yan, R., Liu, M., Bai, Y., Liang, G., Zhang, X., Hu, X., Chen, J., Huang, C., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.03.043 · Cited by 38
“The DCs mature in the tissue after transporting the foreign peptides to their surface and then migrate to secondary lymph nodes where they activate and expand alloresponsive T cells (Jiang et al., 2004; Kubo et al., 2004; MartIn-Fontecha et al., 2003).”
BackgroundSantoni, G., Morelli, M. B., Amantini, C., Nabissi, M., Santoni, M., & Santoni, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00739 · Cited by 34
Recruitment of dendritic cells to pathological niches in inflamed liver
Yoneyama, H., & Ichida, T. (2005) · Medical Molecular Morphology · doi:10.1007/s00795-005-0289-0 · Cited by 34
“The intensity of mDC precursor trafficking would determine the efficiency of local antigen surveillance.(4,19)”
BackgroundLeprosy as a Model of Immunity
Degang, Y., Nakamura, K., Akama, T., Ishido, Y., Luo, Y., Ishii, N., & Suzuki, K. (2013) · Future Microbiology · doi:10.2217/fmb.13.140 · Cited by 35
Salem, M. L., & Cole, D. J. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0792-6 · Cited by 36
“Conditioning lymph nodes, for example with pre-injection of naïve unpulsed DCs or inXammatory cytokines, such as TNF- , can signiWcantly enhance the migration and retention of exogenous DCs, resulting in a robust anti-tumor immunity [78].”
Oncolytic viruses: a step into cancer immunotherapy
Lichty, B. D., Pol, J. G., & Resseguier (2011) · Virus Adaptation and Treatment · doi:10.2147/vaat.s12980 · Cited by 33
Toomey, D., Conroy, H., Jarnicki, A., Higgins, S. C., Sutton, C. E., & Mills, K. H. G. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.005 · Cited by 35
In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide
Hu, Q. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24307 · Cited by 33
“International Journal of Nanomedicine 2011:6 migration of these cells from the periphery to T cells via afferent lymphatics to generate potent immune responses.(12) The dendritic cell migration process is complicated, involving a number of molecules, including chemokines, chemotactic receptors, adhesion molecules, and…”
Jak3 Is Involved in Dendritic Cell Maturation and CCR7-Dependent Migration
Rivas-Caicedo, A., Soldevila, G., van der Goes, T. I. F., Castell-Rodríguez, A. E., Flores‐Romo, L., & García-Zepeda, E. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007066 · Cited by 36
“Migration of mature DCs to LN occurs through the afferent lymphatics and has been shown to involve CCR7-mediated signalling [23], as assessed by the decreased homing of DCs into the lymph nodes observed in CCR7 mice [24] or in plt/plt mice [8].”
BackgroundJie, Z., Liang, Y., Yi, P., Tang, H. J., Soong, L., Cong, Y., Zhang, K., & Sun, J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601891 · Cited by 34
“Under the appropriate liver microenvironment, these DCs have the unique capability of egress from the infective sites to draining lymphoid organs (24, 25).”
BackgroundMcCarthy, M. K., Davenport, B., Reynoso, G. V., Lucas, E. D., May, N. A., Elmore, S. A., Tamburini, B. A. J., Hickman, H. D., & Morrison, T. E. (2018) · JCI Insight · doi:10.1172/jci.insight.121100 · Cited by 35
MTAP deficiency contributes to immune landscape remodelling and tumour evasion
Chang, W., Hsu, S., Zhang, J., Li, J., Yang, D. C. H., Chu, C., Yoo, E. H., Zhang, W., Yu, S., & Chen, C. (2022) · Immunology · doi:10.1111/imm.13587 · Cited by 34
“The migratory ability of tumour-infiltrating DCs into TDLNs depends on the expression of CCR7 chemokine receptor [35].”
BackgroundZettlitz, K. A., Tavaré, R., Tsai, W. K., Yamada, R. E., Ha, N. S., Collins, J., van Dam, R. M., Timmerman, J. M., & Wu, A. M. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4214-x · Cited by 32
Fink, C., Smith, M. H., Gaudet, J. M., Makela, A. V., Foster, P. J., & Dekaban, G. A. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01393-8 · Cited by 32
“In fact, the number of DC reaching a lymph node is predictive of the magnitude of the resulting TAA-specific immune response [5, 6].”
BackgroundMethodA potential novel cancer immunotherapy: Agonistic anti-CD40 antibodies
Jian, C.-Z., Li, L., Hsu, C., Chen, Y.-H., Hsu, C., Tan, C., & Ou, D. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103893 · Cited by 32
Improved Efficacy of Dendritic Cell–Based Immunotherapy by Cutaneous Laser Illumination
Chen, X., Zeng, Q., & Wu, M. X. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2654 · Cited by 32
Salter, R. D., & Shurin, M. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4 · Cited by 34
Hedman, M., Faresjö, M., Axelsson, S., Ludvigsson, J., & Casas, R. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03720.x · Cited by 32
Edsen-Moore, M., Fan, J., Ness, K. J., Marietta, J. R., Cook, R. T., & Schlueter, A. J. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00699.x · Cited by 32
“In fact, the effect of DC loss may be amplified at the T cell activation stage of the immune response, as a 2-fold loss of DC has been reported to result up to 4-fold decrease in activated T cells (Martı́n-Fontecha et al., 2003).”
Wu, W., Ho, L., Chang, D., Chen, C., & Lai, J. (2009) · European Journal of Immunology · doi:10.1002/eji.200939306 · Cited by 33
CD40-activated B cells as antigen-presenting cells: the final sprint toward clinical application
Wennhold, K., Shimabukuro‐Vornhagen, A., Theurich, S., & von Bergwelt‐Baildon, M. (2013) · Expert Review of Vaccines · doi:10.1586/erv.13.39 · Cited by 33
LIGHT Regulates Inflamed Draining Lymph Node Hypertrophy
Zhu, M., Yang, Y., Wang, Y., Wang, Z., & Fu, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002097 · Cited by 31
“pression in the skin are critical for DC migration to DLN (5, 22).”
BackgroundWheat, W. H., Pauken, K. E., Morris, R. V., & Titus, R. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8286 · Cited by 31
“Typically, maturing peripheral DCs are able to migrate and arrive in their cognate draining lymph node in as little as 2 h post-Ag exposure (41).”
BackgroundLeleux, J. A., Atalis, A., & Roy, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.063 · Cited by 31
Qian, J., Xu, X., Ding, J., Yin, R., Sun, Y., Xue, C., Wang, J., Ding, C., Yu, S., Liu, X., et al. (2017) · Veterinary Microbiology · doi:10.1016/j.vetmic.2017.03.002 · Cited by 33
“DC migration, a critical step for mature DC (mDC)-initiated immune response, is collaborated by a complex interaction between chemokines and their receptors (Martínfontecha et al., 2003).”
BackgroundAntigen delivery by dendritic cells
Moll, H. (2004) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2004.03.003 · Cited by 36
Wong, J. L., Muthuswamy, R., Bartlett, D. L., & Kaliński, P. (2013) · OncoImmunology · doi:10.4161/onci.26245 · Cited by 32
Alaniz, L. D., Rizzo, M., García, M. G., Piccioni, F., Aquino, J. B., Malvicini, M., Atorrasagasti, C., Bayo, J., Echeverria, I., Sarobe, P., et al. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1036-0 · Cited by 30
“Migration to lymph node and precise positioning of DC is critical to induce immunity against cancer [11, 34] and it is a challenge for DC-based vaccine protocols [35, 36].”
Backgroundde Chickera, S., Willert, C., Mallet, C., Foley, R., Foster, P. J., & Dekaban, G. A. (2011) · International Immunology · doi:10.1093/intimm/dxr095 · Cited by 32
A spatial model of the efficiency of T cell search in the influenza-infected lung
Levin, D., Forrest, S., Banerjee, S., Clay, C. C., Cannon, J. L., Moses, M. E., & Koster, F. T. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2016.02.022 · Cited by 34
“T cell production is assumed to be constant after day 5 (Martin-Fontecha et al., 2003).”
Influence of synthetic superparamagnetic iron oxide on dendritic cells
Hu, Q. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s23240 · Cited by 30
“Essentially, dendritic cells induce potent immune responses via their ability to migrate from the periphery via afferent lymphatics to areas containing T cells in secondary lymphoid organs.(8) In te rn at io na l J ou rn al o f N an om ed ic in e do w nl oa de d fr om h ttp s: //w w w .”
Ehser, S., Chuang, J. J., Kleist, C., Șandra-Petrescu, F., Iancu, M., Wang, D., Opelz, G., & Terness, P. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.01.018 · Cited by 30
Chemokines and Their Receptors in Islet Allograft Rejection and as Targets for Tolerance Induction
Merani, S., Truong, W., Hancock, W. W., Anderson, C. C., & Shapiro, A. M. J. (2006) · Cell Transplantation · doi:10.3727/000000006783981963 · Cited by 31
Zhao, C., Wood, M. W., Galyov, E. E., Höpken, U. E., Lipp, M., Bodmer, H. C., Tough, D. F., & Carter, R. W. (2006) · European Journal of Immunology · doi:10.1002/eji.200636179 · Cited by 37
Self-citationSaint-Mézard, P., Krasteva, M., Bérard, F., Dubois, B., Kaiserlian, D., & Nicolas, J. (2004) · CRC Press eBooks · doi:10.1201/b14248-37 · Cited by 151
Lymphatic Clearance of Immune Cells in Cardiovascular Disease
Ravaud, C., Ved, N., Jackson, D. G., Vieira, J. M., & Riley, P. R. (2021) · Cells · doi:10.3390/cells10102594 · Cited by 30
Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications
Li, W., Yu, C., Zhang, X., Gu, Y., He, X., Xu, R., Xu, J. F., Yu, G., & Wu, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00300-8 · Cited by 30
Migration of Dendritic Cells Facilitates Systemic Dissemination of Burkholderia pseudomallei
Williams, N. L., Morris, J. L., Rush, C. M., & Ketheesan, N. (2014) · Infection and Immunity · doi:10.1128/iai.01880-14 · Cited by 29
“pseudomallei-infected BMDC migrated to the draining LN, a relatively low number compared to published studies on DC migration (34).”
BackgroundResultDendritic Cells as Targets for Biomaterial-Based Immunomodulation
Eslami-Kaliji, F., Sarafbidabad, M., Rajadas, J., & Mohammadi, M. R. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01987 · Cited by 29
Dougan, M. L., & Dranoff, G. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9914-6_22 · Cited by 35
Cross-presentation: how to get there – or how to get the ER
Kreer, C., Rauen, J., Zehner, M., & Burgdorf, S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00087 · Cited by 36
“Since this process is estimated to take up to 48 h (Martin-Fontecha et al., 2003), a prolonged MHC I-restricted presentation is required for efficient T cell activation, implying that ongoing antigen processing and loading of antigen-derived peptides onto MHC I molecules is indispensible.”
BackgroundIn Vitro Approaches to the Identification and Characterization of Skin Sensitizers
Basketter, D. A., & Maxwell, G. (2007) · Cutaneous and Ocular Toxicology · doi:10.1080/15569520701622993 · Cited by 31
“Upon arrival at the dLN the LC, now a mature DC, is guided via its expression of the chemokine receptor CCR7 to T cells in the paracortex (25,26).”
BackgroundHwang, H., Shin, C., Park, J., Kang, E., Choi, B., Han, J., Do, Y., Ryu, S., & Cho, Y. (2016) · Scientific Reports · doi:10.1038/srep30207 · Cited by 29
Role of calcium permeable channels in dendritic cell migration
Sáez, P. J., Sáez, J. C., Lennon‐Duménil, A., & Vargas, P. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.04.005 · Cited by 30
Sculpting the immunological response to dengue fever by polytopic vaccination
Zhou, H., & Deem, M. W. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.12.031 · Cited by 31
“Draining to a specific lymph node is especially pronounced in vaccination with antigen-bearing dendritic cells [19, 20].”
BackgroundPeripheral blood manipulation significantly affects the result of dendritic cell monitoring
Gerrits, J. H., Athanassopoulos, P., Vaessen, L. M. B., Klepper, M., Weimar, W. W., & van Besouw, N. M. (2006) · Transplant Immunology · doi:10.1016/j.trim.2006.11.006 · Cited by 29
IRAK-M Removal Counteracts Dendritic Cell Vaccine Deficits in Migration and Longevity
Turnis, M. E., Song, X., Bear, A. S., Foster, A. E., Gottschalk, S. M., Brenner, M. K., Chen, S., & Rooney, C. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903507 · Cited by 29
“creased expression of the CCR7 receptor (27, 37).”
BackgroundReschke, R., & Olson, D. (2022) · Cancers · doi:10.3390/cancers14102458 · Cited by 28
Maio, M., Barros, J., Joly, M., Vahlas, Z., Franco, J. L. M., Genoula, M., Monard, S., Vecchione, M. B., Fuentes, F., Polo, V. G., et al. (2024) · eLife · doi:10.7554/elife.89319 · Cited by 29
Xiao, Q., & Xia, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1140765 · Cited by 33
“The gradient of CCL21 drived the directional DC migration to lymph nodes (Förster et al., 1999; MartIn-Fontecha et al., 2003; Ohl et al., 2004; Weber et al., 2013).”
BackgroundSchulz, O., Ugur, M., Friedrichsen, M., Radulovic, K., Niess, J. H., Jalkanen, S., Krueger, A., & Pabst, O. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.105 · Cited by 29
Sun, Y., Qian, J., Xu, X., Tang, Y., Xu, W., Yang, W., Jiang, Y., Yang, G., Ding, Z., Cong, Y., et al. (2018) · Veterinary Microbiology · doi:10.1016/j.vetmic.2018.07.009 · Cited by 29
Vitamin D as a Potential Therapy for Multiple Sclerosis: Where Are We?
Wasnik, S., Sharma, I., Baylink, D. J., & Tang, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093102 · Cited by 31
A key role for PTP1B in dendritic cell maturation, migration, and T cell activation
Martín‐Granados, C., Prescott, A. R., Sommer, S. L., Klaska, I. P., Tian, Y., Muckersie, E., Giuraniuc, C. V., Grant, L., Delibegović, M., & Forrester, J. V. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv032 · Cited by 28
“In agreement with other reports (MartIn-Fontecha et al., 2003), we found that DC migrate from the subcutaneous tissues to the DLN under homeostatic conditions in small numbers, a mechanism that is considered as part of the process of at U niersity of M antoba on Jne (1)6, 2015 htp://jm cb.”
ResultVillablanca, E. J., Zhou, D., Valentinis, B., Negro, A., Raccosta, L., Mauri, L., Prinetti, A., Sonnino, S., Bordignon, C., Traversari, C., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108047 · Cited by 32
“The late step of the DC maturation program [2] is characterized by the expression of a well-defined set of chemokine receptors, CCR7, and CXCR4, allowing DC migration to secondary lymphoid organs (SLO) and favoring the cognate interaction of mature DCs with T/B cells in these sites [3–7].”
BackgroundKuang, Y., Weiyang, H., Simin, L., & Xin, G. (2018) · Journal of Immunology Research · doi:10.1155/2018/5808962 · Cited by 29
“The transfer of CCR7-deficient DCs leads to the recovery of less than one-tenth the number of DCs from the lymph node compared with the transfer of CCR7 DCs [34], and DCs differentiated from the bone marrow of CCR7-deficient mice do not move to the draining lymph nodes following their subcutaneous injection or intratr…”
BackgroundNeumann, S., Boothman-Burrell, L., Gowing, E. K., Jacobsen, T. A., Ahring, P. K., Young, S. L., Sandager‐Nielsen, K., & Clarkson, A. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01133 · Cited by 30
“The production of pro-inflammatory cytokines and expression of activation markers on innate immune cells has been previously observed to impact the priming of naïve T-cells and drives the polarization of T-cells toward a distinct effector function (Martin-Fontecha et al., 2003; Joffre et al., 2009).”
BackgroundCooper, A. J. R., Lalor, S. J., & McLoughlin, R. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000143 · Cited by 31
Two-photon microscopy of host-pathogen interactions: acquiring a dynamic picture of infectionin vivo
Konjufca, V. H., & Miller, M. J. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01289.x · Cited by 29
“In peripheral tissues, DCs mediate the transport of foreign antigen from peripheral tissues to draining lymph nodes for presentation to T cells (MartIn-Fontecha et al., 2003).”
BackgroundThe role of CCR7 in allergic airway inflammation induced by house dust mite exposure
Kawakami, M., Narumoto, O., Matsuo, Y., Horiguchi, K., Horiguchi, S., Yamashita, N., Sakaguchi, M., Lipp, M., Nagase, T., & Yamashita, N. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.03.009 · Cited by 29
“When dendritic cell immobilize antigen, their phenotype changes to mature type and express CCR7 to migrate secondary lymph node [23,29,30].”
BackgroundSelf-citationHartiala, P., Hytönen, J., Pelkonen, J., Kimppa, K., West, A., Penttinen, M. A., Suhonen, J., Lahesmaa, R., & Viljanen, M. K. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106709 · Cited by 28
“dothelial cells, and DC themselves [5].”
BackgroundDendritic Cell–Based Vaccination Against Cancer
Saito, H., Frleta, D., Dubsky, P. C., & Palucka, K. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.02.011 · Cited by 30
“DC migration was improved in a mouse study by conditioning the injection site with TNF, which significantly increased DC migration to the draining lymph nodes and the magnitude of the CD4 T cell response [125].”
BackgroundOyarce, C., Cruz, S. R., Gálvez‐Cancino, F., Vargas, P., Moreau, H. D., Díaz‐Valdivia, N., Díaz, J., Salazar‐Onfray, F., Pacheco, R., Lennon‐Duménil, A., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01794 · Cited by 27
RAF kinases are stabilized and required for dendritic cell differentiation and function
Riegel, K., Schlöder, J., Sobczak, M., Jonuleit, H., Thiede, B., Schild, H., & Rajalingam, K. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0416-4 · Cited by 28
“Furthermore, RAF inhibition had a negative effect on the mRNA expression of the chemokine receptor CCR7, which directs mature DCs to the draining lymph nodes [29] (Fig.”
BackgroundCXCR4 Is Dispensable for T Cell Egress from Chronically Inflamed Skin via the Afferent Lymph
Geherin, S. A., Wilson, R. P., Jennrich, S., & Debes, G. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095626 · Cited by 28
“[11,34,35]), it is downregulated on the transcriptional level in cutaneous LECs in the oxazolone-challenge model of contact hypersensitivity [17].”
BackgroundRizzo, M., Bayo, J., Piccioni, F., Malvicini, M., Fiore, E. J., Peixoto, E., García, M. G., Aquino, J. B., Campaña, A. G., Podestá, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107944 · Cited by 26
“We have previously demonstrated both in vivo and in vitro that DC pre-conditioning with low molecular weight hyaluronan (LMW HA) is able to enhance DC migration toward regional lymph nodes in mice [10].”
BackgroundLi, J., Southerland, L. T., Lu, Y., Darlak, K. A., Giver, C. R., McMillin, D. W., Harris, W. A. C., Jaye, D. L., & Waller, E. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900155 · Cited by 29
“Host APCs persist after high-dose chemotherapy (1), HSCT, and HSCT (2, 3) and initiate GvHD in mouse models of HSCT (4–6).”
BackgroundLymph node γδ and αβ CD8+ T cells share migratory properties
Ugur, M., Kaminski, A., & Pabst, O. (2018) · Scientific Reports · doi:10.1038/s41598-018-27339-8 · Cited by 26
In Vivo Generation of Gut-Homing Regulatory T Cells for the Suppression of Colitis
Xu, Y., Cheng, Y., Baylink, D. J., Wasnik, S., Goel, G., Huang, M., Cao, H. L., Qin, X., Lau, K. ‐. W., Chan, C., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800018 · Cited by 26
“In conclusion, the DC-CYP-ALDH cells can survive in vivo for a period of time similar to parental DCs (40), and they stably”
BackgroundFine-tuning immune surveillance by fever-range thermal stress
Fisher, D. T., Vardam, T. D., Muhitch, J. B., & Evans, S. S. (2009) · Immunologic Research · doi:10.1007/s12026-009-8122-9 · Cited by 26
“Collectively, these leukocytes license antigenpresenting cells to prime T cell activation and support the ensuing development of the immunoprotective response [11–14].”
BackgroundParlet, C. P., & Schlueter, A. J. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12201 · Cited by 26
Dendritic Cell-Based Approaches for Therapeutic Immune Regulation in Solid-Organ Transplantation
Vassalli, G. (2013) · Journal of Transplantation · doi:10.1155/2013/761429 · Cited by 30
“[78] A.”
BackgroundNanotheranostic Strategies for Cancer Immunotherapy
Nguyen, A., Kumar, S., & Kulkarni, A. A. (2022) · Small Methods · doi:10.1002/smtd.202200718 · Cited by 25
Correlation of Contact Sensitizer Potency with T Cell Frequency and TCR Repertoire Diversity
Esser, P. R., Kimber, I., & Martin, S. F. (2013) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-0726-5_8 · Cited by 29
“2) (Kimber et al. 2012b; Kotturi et al. 2008; MartIn-Fontecha et al. 2003; Moon et al. 2007).”
Xia, J., Kong, L. X., Zhou, L., Wu, S., Yao, L.-J., He, C., He, C. Y., & Peng, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00061 · Cited by 25
Remodeling of reactive lymph nodes: Dynamics of stromal cells and underlying chemokine signaling
Thierry, G. R., Gentek, R., & Bajénoff, M. (2019) · Immunological Reviews · doi:10.1111/imr.12750 · Cited by 30
Enioutina, E. Y., Bareyan, D., & Daynes, R. A. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.008 · Cited by 25
Sabado, R. L., Meseck, M. L., & Bhardwaj, N. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3387-7_44 · Cited by 24
Fa(c)t checking: How fatty acids shape metabolism and function of macrophages and dendritic cells
Almeida, L., & Everts, B. (2021) · European Journal of Immunology · doi:10.1002/eji.202048944 · Cited by 30
Chen, Y., Wen, S., Shang, S., Cui, Y., Luo, B. H., & Teng, G. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.09.006 · Cited by 24
Kojima, N., Ishii, M., Kawauchi, Y., & Takagi, H. (2013) · BioMed Research International · doi:10.1155/2013/562924 · Cited by 25
“initiation of cell-mediated immune responses [50], the production and secretion of IL-12 from OML-containing DClike cells may be crucial in the induction of OML-stimulated”
BackgroundModels of dendritic cell development correlate ontogeny with function
Anderson, D. A., & MURPHY, K. M. M. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.09.001 · Cited by 24
Assuring Consumer Safety without Animal Testing: A Feasibility Case Study for Skin Sensitisation
Maxwell, G., Aleksić, M., Aptula, A. O., Carmichael, P. L., helen, F. J., Gilmour, N. J., Mackay, C. D. A., Pease, C. K. S., Pendlington, R. U., Reynolds, F., et al. (2008) · Alternatives to Laboratory Animals · doi:10.1177/026119290803600511 · Cited by 24
“For example, data from pathogen infection studies were used to implement a LN cell recruitment effect in the model (36, 37).”
MethodWang, T., Jiang, Q., Chan, C. W. Y., Gorski, K. S., McCadden, E., Kardian, D., Pardoll, D. M., & Whartenby, K. A. (2009) · Blood · doi:10.1182/blood-2008-08-176354 · Cited by 28
Migration of dendritic cells across blood and lymphatic endothelial barriers
Prete, A. D., Locati, M., Otero, K., Riboldi, E., Mantovani, A., Vecchi, A., & Sozzani, S. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-10-0974 · Cited by 27
Secco, V. D., Soldani, C., Debrat, C., Asperti-Boursin, F., Donnadieu, E., Viola, A., & Sarukhan, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007696 · Cited by 25
Bidirectional MHC molecule exchange between migratory and resident dendritic cells
de Heusch, M., Blocklet, D., Egrise, D., Hauquier, B., Vermeersch, M., Goldman, S., & Moser, M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307167 · Cited by 27
“Sallusto and colleagues [10] have shown that enhancing the number of DCs reaching the lymph nodes increases the number of CD4 transgenic T cells, which proliferate and produce cytokines.”
BackgroundWarncke, M., Dodero, A., Dierbach, H., Follo, M., & Veelken, H. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.09.012 · Cited by 24
Li, J., Zhan, Q., Hu, Y., & Wang, Y. (2019) · Journal of International Medical Research · doi:10.1177/0300060518819606 · Cited by 23
Fink, C., Gevaert, J. J., Barrett, J. W., Dikeakos, J. D., Foster, P. J., & Dekaban, G. A. (2023) · European Radiology Experimental · doi:10.1186/s41747-023-00359-4 · Cited by 24
“First, DC migration to secondary lymphoid organs post injection and subsequent presentation of TAA to prime T cells post injection is required and secondly, quantification of this DC migration correlates with therapeutic potency [7, 8].”
BackgroundAlissafi, T., Hatzioannou, A., Ιωάννου, Μ., Sparwasser, T. D., Grün, J. R., Grützkau, A., & Verginis, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500111 · Cited by 24
Hunyadi, J., András, C., Szabó, I., Szántó, J., Szluha, K., Sipka, S., Kovacs, P. L., Kiss, A., Szegedi, G., Altorjay, I., et al. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9704-3 · Cited by 23
“These clinical trials have established the feasibility and safety of DC-based vaccination approaches [26–29], and in some but not all cancer patients have been associated with immune responses [30], which not always correlated with the immunological results.”
BackgroundObieglo, K., Feng, X., Bollampalli, V. P., Dellacasa-Lindberg, I., Classon, C., Österblad, M., Helmby, H., Hewitson, J. P., Maizels, R. M., Rothfuchs, A. G., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1500970 · Cited by 23
García-Zepeda, E. A., Licona‐Limón, I., Jimenez‐Solomon, M. F., & Soldevila, G. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02634.x · Cited by 23
Park, M.-Y., Kim, C., Sohn, H., Oh, S., Kim, S.-G., & Kim, T. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.08.037 · Cited by 26
Zhang, X., de Chickera, S. N., Willert, C., Economopoulos, V., Noad, J., Rohani, R., Wang, A. Y., Levings, M. K., Scheid, E., Foley, R., et al. (2011) · Cytotherapy · doi:10.3109/14653249.2011.605349 · Cited by 23
Milling, S. W. F., Yrlid, U., Jenkins, C., Richards, C. M., Williams, N., & MacPherson, G. G. (2006) · European Journal of Immunology · doi:10.1002/eji.200636199 · Cited by 23
Geiger-Schuller, K., Eraslan, B., Kuksenko, O., Dey, K. K., Jagadeesh, K. A., Thakore, P. I., Karayel, Ö., Yung, A. R., Rajagopalan, A. R., Meireles, A. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.23.525198 · Cited by 27
Metadata
- Authors
- Martín-Fontecha, A., Sebastiani, S., Höpken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., & Sallusto, F.
- Affiliations
- 1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
- Institute for Research in Biomedicine (CH)
- 2Max Delbrück Center for Molecular Medicine, 13122 Berlin-Buch, Germany
- Max Delbrück Center (DE)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-08-18
- Volume
- 198
- Issue
- 4
- Pages
- 615-621
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194169
- OpenAlex
- W2149057253
- Cited by
- 878
- References
- 29
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 16 · 2023: 24 · 2022: 15 · 2021: 28 · 2020: 27 · 2019: 31 · 2018: 33 · 2017: 37 · 2016: 39 · 2015: 28 · 2014: 29 · 2013: 57 · 2012: 30
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Science Foundation
- Institute for Research in Biomedicine
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (63885)
- Helmut Horten Stiftung
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cell migration, draining lymph nodes, CCR7, CCL21, lymphatic endothelial cells, inflammatory cytokines, TNF-α, CD4+ T cell responses, antigen-pulsed dendritic cells, dendritic cell vaccine, lymph node cellularity, tissue inflammation
- MeSH terms
- Animals, Cell Movement, Dendritic Cells, Fluorescent Dyes, Humans, Interleukin-1, Lymph Nodes, Mice, Inbred BALB C, T-Lymphocytes, Tumor Necrosis Factor-alpha, Cell Transplantation, Receptors, Chemokine, Mice, Receptors, CCR7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.